61 – 70 of 149
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Caregiver Burden and Quality of Life in Late Stage Parkinson’s Disease
- Contribution to journal › Article
-
Mark
Quality of life and resource utilization-Swedish data from the Care of Late-Stage Parkinsonism (CLaSP) study
M. Norlin, Jenny ; Hjalte, Frida ; Kruse, Christopher ; Dodel, Richard ; Rosqvist, Kristina LU and Odin, Per LU
(2022)
In Acta Neurologica Scandinavica
145(6).
p.743-752
- Contribution to journal › Article
-
Mark
Validation of the PD home diary for assessment of motor fluctuations in advanced Parkinson's disease
Löhle, Matthias ; Bremer, Alexander ; Gandor, Florin ; Timpka, Jonathan LU ; Odin, Per LU
; Ebersbach, Georg
and Storch, Alexander
(2022)
In npj Parkinson's Disease
8(1).
- Contribution to journal › Article
-
Mark
Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain : rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial
Chaudhuri, K. Ray ; Odin, Per LU
; Ferreira, Joaquim J.
; Antonini, Angelo
; Rascol, Olivier
; Kurtis, Mónica M.
; Storch, Alexander
; Bannister, Kirsty
; Soares-da-Silva, Patrício
and Costa, Raquel
, et al.
(2022)
In BMC Neurology
22(1).
- Contribution to journal › Article
-
Mark
Safinamide in the treatment pathway of Parkinson’s Disease : a European Delphi Consensus
Stocchi, Fabrizio ; Antonini, Angelo ; Berg, Daniela ; Bergmans, Bruno ; Jost, Wolfgang ; Katzenschlager, Regina ; Kulisevsky, Jaime ; Odin, Per LU
; Valldeoriola, Francesc
and Ray Chaudhuri, K.
(2022)
In npj Parkinson's Disease
8.
- Contribution to journal › Article
-
Mark
Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson’s disease
Raket, Lars Lau LU
; Oudin Åström, Daniel
LU
; Norlin, Jenny M.
; Kellerborg, Klas
; Martinez-Martin, Pablo
and Odin, Per
LU
(2022)
In Scientific Reports
12(1).
- Contribution to journal › Article
-
Mark
Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries
Malaty, Irene A. ; Martinez-Martin, Pablo ; Chaudhuri, K. Ray ; Odin, Per LU
; Skorvanek, Matej
; Jimenez-Shahed, Joohi
; Soileau, Michael J.
; Lindvall, Susanna
; Domingos, Josefa
and Jones, Sarah
, et al.
(2022)
In BMC Neurology
22(1).
- Contribution to journal › Article
-
Mark
Gait and balance among people with de novo vs. mild to moderate Parkinson’s disease
Lindholm, Beata LU
; Hagell, Peter
LU
; Odin, Per
LU
; Dahlin, Lars
LU
and Franzén, Erika
(2022)
6th International Conference on Neurology and Brain Disorders (Virtual)
- Contribution to conference › Abstract
-
Mark
High risk of developing dementia in Parkinson’s disease : a Swedish registry-based study
Åström, Daniel Oudin LU ; Simonsen, Jacob ; Raket, Lars Lau LU
; Sgarbi, Simona
; Hellsten, Johan
LU
; Hagell, Peter
LU
; Norlin, Jenny M.
; Kellerborg, Klas
; Martinez-Martin, Pablo
and Odin, Per
LU
(2022)
In Scientific Reports
12(1).
- Contribution to journal › Article
-
Mark
Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease?
Rota, Silvia ; Urso, Daniele ; van Wamelen, Daniel J. ; Leta, Valentina ; Boura, Iro ; Odin, Per LU
; Espay, Alberto J.
; Jenner, Peter
and Chaudhuri, K. Ray
(2022)
In Translational Neurodegeneration
11(1).
- Contribution to journal › Scientific review